- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
Total 216 results
-
Ruijin HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingRectal Cancer | Locally Advanced
-
Chinese PLA General HospitalUnknown
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Grit BiotechnologyNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarcinoma, HepatocellularChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | Triple-Negative Breast CancerChina
-
Chinese PLA General HospitalZhejiang UniversityRecruitingLymphoma | Solid Tumor, Adult | EphA2 Overexpression | TP53 R273H | TP53 R175H | TP53 R248Q | TP53 R249SChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the Liver | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Unresectable Colorectal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the RectumUnited States
-
M.D. Anderson Cancer CenterRecruitingChondrosarcoma | Advanced Malignant Solid Neoplasm | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Stage IVA Uterine Corpus Cancer AJCC v8 | Stage IVB Uterine Corpus Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous... and other conditionsUnited States
-
Chinese PLA General HospitalUnknownBiliary Tract Cancer (BTC)China
-
Henlix, IncUnknownHepatitis B, ChronicTaiwan
-
Chinese PLA General HospitalZhejiang UniversityRecruitingSolid Tumor, Adult | KRAS G12D | EphA2 Overexpression | KRAS G12V | KRAS G12CChina
-
Sinocelltech Ltd.TerminatedSquamous-cell Non-Small-cell Lung CancerChina
-
Qilu Pharmaceutical Co., Ltd.Terminated
-
Chinese PLA General HospitalRecruitingColorectal Neoplasms | Colorectal Cancer | Microsatellite Stable Colorectal Carcinoma | RAS MutationChina
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawnHepatocellular CarcinomaChina
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSmall Intestinal Adenocarcinoma | Stage III Small Intestinal Adenocarcinoma AJCC v8 | Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 | Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 | Stage IV Small Intestinal Adenocarcinoma AJCC v8 | Ampulla of Vater Adenocarcinoma | Stage III Ampulla... and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingGastric Cancer | Diffuse Type CarcinomaChina
-
Stanford UniversityMerck Sharp & Dohme LLCRecruitingHodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin LymphomaUnited States
-
Peking University Cancer Hospital & InstituteNot yet recruiting
-
Shanghai Henlius BiotechWithdrawn
-
Ruijin HospitalRecruitingEsophageal Squamous Cell CarcinomaChina
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Cervical CarcinomaChina
-
Yancheng First People's HospitalRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; The Affiliated Hospital Of Guizhou... and other collaboratorsRecruitingHigh-Risk Cancer | Early-stage | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Huazhong University of Science and TechnologyChongqing University Cancer Hospital; Peking University People's Hospital; Qilu... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
National Cancer Institute (NCI)CompletedAdvanced Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Advanced Sarcomatoid Renal Cell CarcinomaUnited States
-
Zhejiang UniversityZcapsule Pharmaceuticals (Shaoxing) Co., LtdRecruitingOvarian Cancer | Bladder Cancer | Small-cell Lung Cancer | Liver Cancer | Esophagus CancerChina
-
Bio-Thera SolutionsRecruiting
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Northwestern UniversityNational Cancer Institute (NCI); NovoCure Ltd.RecruitingAtypical Meningioma | Grade III Meningioma | Recurrent Meningioma | Anaplastic (Malignant) Meningioma | Grade II Meningioma | Supratentorial MeningiomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Fudan UniversityRecruitingHigh-Risk Localized Soft Tissue SarcomaChina
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Bio-Thera SolutionsWuhan Union Hospital, ChinaActive, not recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)TerminatedRecurrent Squamous Cell Lung Carcinoma | Recurrent Lung Adenocarcinoma | Stage IV Lung Adenocarcinoma | Recurrent Large Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma | Stage IV Large Cell Lung CarcinomaUnited States, Mexico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Ovarian Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)CompletedGlioblastoma | Gliosarcoma | Recurrent Brain NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
Ruijin HospitalNot yet recruitingMuscle-Invasive Bladder CarcinomaChina
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Fudan UniversityRecruitingAdenocarcinoma | Metastatic Cancer | Metastatic Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Oligometastatic Disease | Stomach Neoplasm | Adenocarcinoma of the Stomach | Gastroesophageal-junction Cancer | Metastatic AdenocarcinomaChina
-
Peking University Cancer Hospital & InstituteNot yet recruiting